We examined the relationship between OAS1 expression and Tumor Mutational Burden and Microsatellite Instability, both of which have been linked to the formation of tumor neoantigens and the effectiveness of immune checkpoint blockade therapy (64, 65). This evidence concerns the gene OAS1 and neoplasm.